Citations (82)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Kristina Groti Antonič. (2022) Impact of testosterone therapy on bone turnover markers in obese males with type 2 diabetes and functional hypogonadism. The Aging Male 25:1, pages 269-277.
Read now
Read now
Bruno Lunenfeld, George Mskhalaya, Michael Zitzmann, Giovanni Corona, Stefan Arver, Svetlana Kalinchenko, Yuliya Tishova & Abraham Morgentaler. (2021) Recommendations on the diagnosis, treatment and monitoring of testosterone deficiency in men. The Aging Male 24:1, pages 119-138.
Read now
Read now
Thomas Greither, Carina Wenzel, Julia Jansen, Matthias Kraus, Martin Wabitsch & Hermann M. Behre. (2020) MiR-130a in the adipogenesis of human SGBS preadipocytes and its susceptibility to androgen regulation. Adipocyte 9:1, pages 197-205.
Read now
Read now
Tom E. Nightingale, Pamela Moore, Joshua Harman, Refka Khalil, Ranjodh S. Gill, Teodoro Castillo, Robert A. Adler & Ashraf S. Gorgey. (2018) Body composition changes with testosterone replacement therapy following spinal cord injury and aging: A mini review. The Journal of Spinal Cord Medicine 41:6, pages 624-636.
Read now
Read now
Giulia Rastrelli, Mauro Dicuio, Yacov Reismann, Alessandra Sforza, Mario Maggi & Giovanni Corona. (2018) Cardiovascular impact of testosterone therapy for hypogonadism. Expert Review of Cardiovascular Therapy 16:9, pages 617-625.
Read now
Read now
Amanda Rao, Elizabeth Steels, Warrick J. Inder, Suzanne Abraham & Luis Vitetta. (2016) Testofen, a specialised Trigonella foenum-graecum seed extract reduces age-related symptoms of androgen decrease, increases testosterone levels and improves sexual function in healthy aging males in a double-blind randomised clinical study. The Aging Male 19:2, pages 134-142.
Read now
Read now
Bruno Lunenfeld, George Mskhalaya, Michael Zitzmann, Stefan Arver, Svetlana Kalinchenko, Yuliya Tishova & Abraham Morgentaler. (2015) Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. The Aging Male 18:1, pages 5-15.
Read now
Read now
Giovanni Corona, Elisa Maseroli, Giulia Rastrelli, Andrea M Isidori, Alessandra Sforza, Edoardo Mannucci & Mario Maggi. (2014) Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis. Expert Opinion on Drug Safety 13:10, pages 1327-1351.
Read now
Read now
Yilmaz Aslan, Ozer Guzel, Melih Balci, Altug Tuncel, Muslum Yildiz & Ali Atan. (2014) The impact of metabolic syndrome on serum total testosterone level in patients with erectile dysfunction. The Aging Male 17:2, pages 76-80.
Read now
Read now
Claire Pexman-Fieth, Hermann M. Behre, Alvaro Morales, Natalia Kan-Dobrosky & Michael G. Miller. (2014) A 6-month observational study of energy, sexual desire, and body proportions in hypogonadal men treated with a testosterone 1% gel. The Aging Male 17:1, pages 1-11.
Read now
Read now
Bruno Lunenfeld, George Mskhalaya, Svetlana Kalinchenko & Yulia Tishova. (2013) Recommendations on the diagnosis, treatment and monitoring of late-onset hypogonadism in men – a suggested update. The Aging Male 16:4, pages 143-150.
Read now
Read now
Josep Rodriguez-Tolrà, Josep Torremadé Barreda, Luis del Rio, Silvana di Gregorio & Eladio Franco Miranda. (2013) Effects of testosterone treatment on body composition in males with testosterone deficiency syndrome. The Aging Male 16:4, pages 184-190.
Read now
Read now
Articles from other publishers (70)
Rossella Cannarella, Carmelo Gusmano, Claudia Leanza, Vincenzo Garofalo, Andrea Crafa, Federica Barbagallo, Rosita A Condorelli, Sandro La Vignera & Aldo E Calogero. (2023) Testosterone replacement therapy and vascular thromboembolic events: a systematic review and meta-analysis. Asian Journal of Andrology.
Crossref
Crossref
Aayushi Sood, Alireza Hosseinpour, Akshit Sood, Sreekant Avula, Jawahar Durrani, Vishal Bhatia & Rahul Gupta. (2023) Cardiovascular Outcomes of Hypogonadal Men Receiving Testosterone Replacement Therapy: A Meta-analysis of Randomized Controlled Trials. Endocrine Practice.
Crossref
Crossref
Lello Zolla. (2023) Biomarkers to Be Used for Decision of Treatment of Hypogonadal Men with or without Insulin Resistance. Metabolites 13:6, pages 681.
Crossref
Crossref
E. A. Troshina & Р. A. Terekhov. (2023) Hypogonadism and visceral obesity in men are full–fledged components of the metabolic syndrome. Obesity and metabolism 20:1, pages 84-91.
Crossref
Crossref
Danae C. Gross, Ray Cheever & John A. Batsis. 2020. Metabolic Syndrome. Metabolic Syndrome
1
18
.
Bin Zeng, Shi Qiu, Xingyu Xiong, Xingyang Su, Zilong Zhang, Qiang Wei & Lu Yang. (2022) The effect of different administrations of testosterone therapy on adverse prostate events: A Bayesian network meta-analysis. Frontiers in Endocrinology 13.
Crossref
Crossref
Ka Youn Lee, Seung-Hyung Kim, Won-Kyung Yang & Geung-Joo Lee. (2022) Effect of Tetragonia tetragonoides (Pall.) Kuntze Extract on Andropause Symptoms. Nutrients 14:21, pages 4572.
Crossref
Crossref
Lello Zolla. (2022) On the Need to Distinguish between Insulin-Normal and Insulin-Resistant Patients in Testosterone Therapy. International Journal of Molecular Sciences 23:21, pages 12730.
Crossref
Crossref
Kazuyoshi Shigehara, Yuki Kato, Kouji Izumi & Atsushi Mizokami. (2022) Relationship between Testosterone and Sarcopenia in Older-Adult Men: A Narrative Review. Journal of Clinical Medicine 11:20, pages 6202.
Crossref
Crossref
Tommaso Cai, Salvatore Privitera, Federica Trovato, Paolo Capogrosso, Federico Dehò, Sebastiano Cimino, Michele Rizzo, Giovanni Liguori, Andrea Salonia, Alessandro Palmieri, Paolo Verze & Truls E. Bjerklund Johansen. (2022) A Proposal of a New Nomogram to Predict the Need for Testosterone ReplACEment (TRACE): A Simple Tool for Everyday Clinical Practice. Journal of Personalized Medicine 12:10, pages 1654.
Crossref
Crossref
Jemma Hudson, Moira Cruickshank, Richard Quinton, Lorna Aucott, Magaly Aceves-Martins, Katie Gillies, Shalender Bhasin, Peter J Snyder, Susan S Ellenberg, Mathis Grossmann, Thomas G Travison, Emily J Gianatti, Yvonne T van der Schouw, Marielle H Emmelot-Vonk, Erik J Giltay, Geoff Hackett, Sudarshan Ramachandran, Johan Svartberg, Kerry L Hildreth, Kristina Groti Antonic, Gerald B Brock, J Lisa Tenover, Hui Meng Tan, Christopher Ho Chee Kong, Wei Shen Tan, Leonard S Marks, Richard J Ross, Robert S Schwartz, Paul Manson, Stephen Roberts, Marianne Skovsager Andersen, Line Velling Magnussen, Rodolfo Hernández, Nick Oliver, Frederick Wu, Waljit S Dhillo, Siladitya Bhattacharya, Miriam Brazzelli & Channa N Jayasena. (2022) Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis. The Lancet Healthy Longevity 3:6, pages e381-e393.
Crossref
Crossref
G. Corona, W. Vena, A. Pizzocaro, V. A. Giagulli, D. Francomano, G. Rastrelli, G. Mazziotti, A. Aversa, A. M. Isidori, R. Pivonello, L. Vignozzi, E. Mannucci, M. Maggi & A. Ferlin. (2022) Testosterone supplementation and bone parameters: a systematic review and meta-analysis study. Journal of Endocrinological Investigation 45:5, pages 911-926.
Crossref
Crossref
Biagio Barone, Luigi Napolitano, Marco Abate, Luigi Cirillo, Pasquale Reccia, Francesco Passaro, Carmine Turco, Simone Morra, Francesco Mastrangelo, Antonio Scarpato, Ugo Amicuzi, Vincenzo Morgera, Lorenzo Romano, Francesco Paolo Calace, Savio Domenico Pandolfo, Luigi De Luca, Achille Aveta, Enrico Sicignano, Massimiliano Trivellato, Gianluca Spena, Carlo D’Alterio, Giovanni Maria Fusco, Raffaele Vitale, Davide Arcaniolo & Felice Crocetto. (2022) The Role of Testosterone in the Elderly: What Do We Know?. International Journal of Molecular Sciences 23:7, pages 3535.
Crossref
Crossref
Sally M. Safwat, Abdelaziz M. Hussein, Elsayed A. Eid, Mohamed S. Serria, Basem H. Elesawy & Hussein F. Sakr. (2022) Dehydroepiandrosterone (DHEA) Improves the Metabolic and Haemostatic Disturbances in Rats with Male Hypogonadism. Scientia Pharmaceutica 90:1, pages 6.
Crossref
Crossref
Prachi Singh, Naima Covassin, Kara Marlatt, Kishore M. Gadde & Steven B. Heymsfield. 2011. Comprehensive Physiology. Comprehensive Physiology
2949
2993
.
Abdulmaged M. Traish. (2021) Age-Related Testosterone Deficiency Merits Treatment. Androgens: Clinical Research and Therapeutics 2:1, pages 46-55.
Crossref
Crossref
Min Ho Lee, Yu Seob Shin & Sung Chul Kam. (2021) Correlation Between Testosterone Replacement Treatment and Lower Urinary Tract Symptoms. International Neurourology Journal 25:1, pages 12-22.
Crossref
Crossref
Zhichao Zhang, Deying Kang & Hongjun Li. (2020) The effects of testosterone on bone health in males with testosterone deficiency: a systematic review and meta-analysis. BMC Endocrine Disorders 20:1.
Crossref
Crossref
Susan J. DiemNancy L. GreerRoderick MacDonaldLauren G. McKenziePhilipp DahmNacide Ercan-FangAllison EstradaLaura S. HemmyChristina E. RosebushHoward A. FinkTimothy J. Wilt. (2020) Efficacy and Safety of Testosterone Treatment in Men: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians. Annals of Internal Medicine 172:2, pages 105.
Crossref
Crossref
Julia Jansen, Thomas Greither & Hermann M. Behre. (2019) Androgen-Regulated microRNAs (AndroMiRs) as Novel Players in Adipogenesis. International Journal of Molecular Sciences 20:22, pages 5767.
Crossref
Crossref
Jennifer S. Walsh, Helen Marshall, Isabelle L. Smith, Diana M. Greenfield, Jayne Swain, Emma Best, James Ashton, Julia M. Brown, Robert Huddart, Robert E. Coleman, John A. Snowden & Richard J. Ross. (2019) Testosterone replacement in young male cancer survivors: A 6-month double-blind randomised placebo-controlled trial. PLOS Medicine 16:11, pages e1002960.
Crossref
Crossref
Marc Gittelman, Jonathan S. Jaffe & Jed C. Kaminetsky. (2019) Safety of a New Subcutaneous Testosterone Enanthate Auto-Injector: Results of a 26-Week Study. The Journal of Sexual Medicine 16:11, pages 1741-1748.
Crossref
Crossref
Abdulmaged M. Traish & Abraham Morgentaler. 2019. Sex Differences in Cardiovascular Physiology and Pathophysiology. Sex Differences in Cardiovascular Physiology and Pathophysiology
321
354
.
Damon E. Houghton, Mouaz Alsawas, Patricia Barrioneuvo, Mouaffaa Tello, Wigdan Farah, Brad Beuschel, Larry J. Prokop, J. Bradley Layton, M. Hassan Murad & Stephan Moll. (2018) Testosterone therapy and venous thromboembolism: A systematic review and meta-analysis. Thrombosis Research 172, pages 94-103.
Crossref
Crossref
Samir Arora, Betsy Moclair, Kyle Murphy, Jonathan S. Jaffe & Jed C. Kaminetsky. (2018) Summative Usability Evaluation of the SCTE-AI Device: A Novel Prefilled Autoinjector for Subcutaneous Testosterone Administration. The Journal of Sexual Medicine 15:12, pages 1707-1715.
Crossref
Crossref
André Tchernof, Dannick Brochu, Ina Maltais‐Payette, Mohamed Fouad Mansour, Geneviève B. Marchand, Anne‐Marie Carreau & Jordanna Kapeluto. 2011. Comprehensive Physiology. Comprehensive Physiology
1253
1290
.
Giovanni Corona, Giulia Rastrelli, Giuseppe Di Pasquale, Alessandra Sforza, Edoardo Mannucci & Mario Maggi. (2018) Testosterone and Cardiovascular Risk: Meta-Analysis of Interventional Studies. The Journal of Sexual Medicine 15:6, pages 820-838.
Crossref
Crossref
Jared W. Skinner, Dana M. Otzel, Andrew Bowser, Daniel Nargi, Sanjay Agarwal, Mark D. Peterson, Baiming Zou, Stephen E. Borst & Joshua F. Yarrow. (2018) Muscular responses to testosterone replacement vary by administration route: a systematic review and meta-analysis. Journal of Cachexia, Sarcopenia and Muscle 9:3, pages 465-481.
Crossref
Crossref
Giuseppina Fanelli, Federica Gevi, Antonio Belardo & Lello Zolla. (2018) Metabolic patterns in insulin-sensitive male hypogonadism. Cell Death & Disease 9:6.
Crossref
Crossref
Michael Grabner, Zsolt Hepp, Amit Raval, Fang Tian & Mohit Khera. (2018) Topical Testosterone Therapy Adherence and Outcomes Among Men With Primary or Secondary Hypogonadism. The Journal of Sexual Medicine 15:2, pages 148-158.
Crossref
Crossref
Abdulmaged M. Traish. (2018) Benefits and Health Implications of Testosterone Therapy in Men With Testosterone Deficiency. Sexual Medicine Reviews 6:1, pages 86-105.
Crossref
Crossref
Julia Rohayem & Eberhard Nieschlag. 2018. Hypothalamic-Pituitary Diseases. Hypothalamic-Pituitary Diseases
289
323
.
Julia Rohayem & Eberhard Nieschlag. 2017. Thyroid Diseases. Thyroid Diseases
1
35
.
Giovanni Corona, Giulia Rastrelli, Mauro Dicuio, Alessandra Sforza & Mario Maggi. (2017) Testosterone and Cardiovascular Diseases: Causes or Consequences: The Lesson from the Last 5 Years. Current Sexual Health Reports 9:4, pages 277-289.
Crossref
Crossref
G Corona, M Dicuio, G Rastrelli, E Maseroli, F Lotti, A Sforza & M Maggi. (2023) Testosterone Treatment and Cardiovascular and Venous Thromboembolism Risk: What is ‘New’?. Journal of Investigative Medicine 65:6, pages 964-973.
Crossref
Crossref
Grace E. Kohn, Taylor P. Kohn & Ranjith Ramasamy. (2017) Effects of Testosterone Replacement Therapy on Lower Urinary Tract Symptoms. Current Bladder Dysfunction Reports 12:2, pages 118-123.
Crossref
Crossref
Y. Nian, M. Ding, S. Hu, H. He, S. Cheng, L. Yi, Y. Li & Y. Wang. (2017) Testosterone replacement therapy improves health-related quality of life for patients with late-onset hypogonadism: a meta-analysis of randomized controlled trials. Andrologia 49:4, pages e12630.
Crossref
Crossref
G. Caleb Alexander, Geetha Iyer, Eleanor Lucas, Dora Lin & Sonal Singh. (2017) Cardiovascular Risks of Exogenous Testosterone Use Among Men: A Systematic Review and Meta-Analysis. The American Journal of Medicine 130:3, pages 293-305.
Crossref
Crossref
Diana Martins, Zhan Yao, Mina Tadrous, Baiju R. Shah, David N. Juurlink, Muhammad M. Mamdani & Tara Gomes. (2017) The appropriateness and persistence of testosterone replacement therapy in Ontario. Pharmacoepidemiology and Drug Safety 26:2, pages 119-126.
Crossref
Crossref
Abraham Morgentaler, M. Zitzmann, A. M. Traish, A. W. Fox, T. H. Jones, M. Maggi, S. Arver, A. Aversa, J.C.N. Chan, A. S. Dobs, G. I. Hackett, W. J. Hellstrom, P. Lim, B. Lunenfeld, G. Mskhalaya, C. C. Schulman & L. O. Torres. (2016) The consensus recommendations of a group of international experts on the fundamental concepts related to the issues of testosterone deficiency and its treatment.. Obesity and metabolism 13:3, pages 15-31.
Crossref
Crossref
Peter Boyle, Alice Koechlin, Maria Bota, Alberto d'Onofrio, David G. Zaridze, Paul Perrin, John Fitzpatrick, Arthur L. Burnett & Mathieu Boniol. (2016) Endogenous and exogenous testosterone and the risk of prostate cancer and increased prostate-specific antigen (PSA) level: a meta-analysis. BJU International 118:5, pages 731-741.
Crossref
Crossref
Andrew Cohen, Brittany Lapin, Chi H. Wang, Brian Helfand, David Victorson & Kristian Novakovic. (2016) Variation in Testosterone Levels and Health-related Quality of Life in Men Diagnosed With Prostate Cancer on Active Surveillance. Urology 94, pages 180-187.
Crossref
Crossref
Abraham Morgentaler, Michael Zitzmann, Abdulmaged M. Traish, Anthony W. Fox, T. Hugh Jones, Mario Maggi, Stefan Arver, Antonio Aversa, Juliana C.N. Chan, Adrian S. Dobs, Geoffrey I. Hackett, Wayne J. Hellstrom, Peter Lim, Bruno Lunenfeld, George Mskhalaya, Claude C. Schulman & Luiz O. Torres. (2016) Fundamental Concepts Regarding Testosterone Deficiency and Treatment. Mayo Clinic Proceedings 91:7, pages 881-896.
Crossref
Crossref
Taylor P. Kohn, Douglas A. Mata, Ranjith Ramasamy & Larry I. Lipshultz. (2016) Effects of Testosterone Replacement Therapy on Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis. European Urology 69:6, pages 1083-1090.
Crossref
Crossref
Heather L. Gelhorn, Margaret K. Vernon, Katie D. Stewart, Michael G. Miller, Meryl Brod, Stanley E. Althof, Leonard R. DeRogatis, Adrian Dobs, Allen D. Seftel & Dennis A. Revicki. (2015) Content Validity of the Hypogonadism Impact of Symptoms Questionnaire (HIS-Q): A Patient-Reported Outcome Measure to Evaluate Symptoms of Hypogonadism. The Patient - Patient-Centered Outcomes Research 9:2, pages 181-190.
Crossref
Crossref
CHANGCHENG GUO, WENYU GU, MIN LIU, BO PENG, XUDONG YAO, BIN YANG & JUNHUA ZHENG. (2016) Efficacy and safety of testosterone replacement therapy in men with hypogonadism: A meta-analysis study of placebo-controlled trials. Experimental and Therapeutic Medicine 11:3, pages 853-863.
Crossref
Crossref
F Saad, A Yassin, G Doros & A Haider. (2015) Effects of long-term treatment with testosterone on weight and waist size in 411 hypogonadal men with obesity classes I-III: observational data from two registry studies. International Journal of Obesity 40:1, pages 162-170.
Crossref
Crossref
John A. Batsis. 2016. Metabolic Syndrome. Metabolic Syndrome
665
678
.
Shin-ichi Hisasue. (2015) Contemporary perspective and management of testosterone deficiency: Modifiable factors and variable management. International Journal of Urology 22:12, pages 1084-1095.
Crossref
Crossref
Matthias Kraus, Thomas Greither, Carina Wenzel, Daniela Bräuer-Hartmann, Martin Wabitsch & Hermann M. Behre. (2015) Inhibition of adipogenic differentiation of human SGBS preadipocytes by androgen-regulated microRNA miR-375. Molecular and Cellular Endocrinology 414, pages 177-185.
Crossref
Crossref
Sabine Kliesch. (2015) Testosteronmangel im Alter: Normal oder pathologisch?. Deutsches Ärzteblatt Online.
Crossref
Crossref
Abdulmaged M. Traish & Michael Zitzmann. (2015) The complex and multifactorial relationship between testosterone deficiency (TD), obesity and vascular disease. Reviews in Endocrine and Metabolic Disorders 16:3, pages 249-268.
Crossref
Crossref
D. M. Kelly & T. H. Jones. (2015) Testosterone and obesity. Obesity Reviews 16:7, pages 581-606.
Crossref
Crossref
L. Xu & C.M. Schooling. (2015) Differential risks in men and women for first and recurrent venous thrombosis: the role of genes and environment: comment. Journal of Thrombosis and Haemostasis 13:5, pages 884-886.
Crossref
Crossref
Abraham Morgentaler, Martin M. Miner, Monica Caliber, Andre T. Guay, Mohit Khera & Abdulmaged M. Traish. (2015) Testosterone Therapy and Cardiovascular Risk: Advances and Controversies. Mayo Clinic Proceedings 90:2, pages 224-251.
Crossref
Crossref
Eberhard Nieschlag. (2015) Current topics in testosterone replacement of hypogonadal men. Best Practice & Research Clinical Endocrinology & Metabolism 29:1, pages 77-90.
Crossref
Crossref
John A. Batsis. 2014. Metabolic Syndrome. Metabolic Syndrome
1
17
.
Abdulmaged M. Traish. (2014) Testosterone and weight loss. Current Opinion in Endocrinology, Diabetes & Obesity 21:5, pages 313-322.
Crossref
Crossref
Abdulmaged M. Traish. (2014) Adverse health effects of testosterone deficiency (TD) in men. Steroids 88, pages 106-116.
Crossref
Crossref
Abdulmaged M. Traish. (2014) Outcomes of testosterone therapy in men with testosterone deficiency (TD): Part II. Steroids 88, pages 117-126.
Crossref
Crossref
Fraser W. Gibb & Mark W.J. Strachan. (2014) Androgen deficiency and type 2 diabetes mellitus. Clinical Biochemistry 47:10-11, pages 940-949.
Crossref
Crossref
Giovanni Corona, Andrea M. Isidori, Jaques Buvat, Antonio Aversa, Giulia Rastrelli, Geoff Hackett, Vincenzo Rochira, Alessandra Sforza, Andrea Lenzi, Edoardo Mannucci & Mario Maggi. (2014) Testosterone Supplementation and Sexual Function: A Meta-Analysis Study. The Journal of Sexual Medicine 11:6, pages 1577-1592.
Crossref
Crossref
Nelson N. Stone, Martin Miner, Wendy L. Poage, Aditi Patel & E. David Crawford. (2014) Male Androgen Deficiency Syndrome Screening Questionnaire: A Simplified Instrument to Identify Testosterone-Deficient Men. Journal of Men's Health 11:1, pages 28-37.
Crossref
Crossref
Aminu K. Bello, Peter Stenvinkel, Meng Lin, Brenda Hemmelgarn, Ravi Thadhani, Scott Klarenbach, Christopher Chan, Deborah Zimmerman, George Cembrowski, Giovanni Strippoli, Juan-Jesus Carrero & Marcello Tonelli. (2014) Serum Testosterone Levels and Clinical Outcomes in Male Hemodialysis Patients. American Journal of Kidney Diseases 63:2, pages 268-275.
Crossref
Crossref
John Roger Andersen, Tor-Ivar Karlsen & Ronette L. Kolotkin. 2014. Integrative Weight Management. Integrative Weight Management
225
235
.
Farid Saad, Ahmad Haider, Gheorghe Doros & Abdulmaged Traish. (2013) Long‐term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss. Obesity 21:10, pages 1975-1981.
Crossref
Crossref
A. A. Yassin & G. Doros. (2013) Testosterone therapy in hypogonadal men results in sustained and clinically meaningful weight loss. Clinical Obesity 3:3-4, pages 73-83.
Crossref
Crossref
Eberhard Nieschlag. (2013) Klinefelter Syndrome. Deutsches Ärzteblatt international.
Crossref
Crossref
Michael Jay Schoenfeld, Emily Shortridge, Zhanglin Cui & David Muram. (2013) Medication Adherence and Treatment Patterns for Hypogonadal Patients Treated with Topical Testosterone Therapy: A Retrospective Medical Claims Analysis. The Journal of Sexual Medicine 10:5, pages 1401-1409.
Crossref
Crossref
Peter T. K. Chan. 2013. Biennial Review of Infertility. Biennial Review of Infertility
31
48
.